Clinical Trial Update: BEAD-T1D: Building the Evidence to Address Disengagement in Type 1 Diabetes [NA]

View source ↗

Summary

The BEAD-T1D trial at Stanford University is currently recruiting to build evidence addressing disengagement in Type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Stanford University | Conditions: Type 1 Diabetes | NA | Status: RECRUITING